119 related articles for article (PubMed ID: 17022146)
21. Establishment of HUOCA-II, a human ovarian clear cell adenocarcinoma cell line, and its angiogenic activity.
Ishiwata I; Ishiwata C; Soma M; Ishikawa H
J Natl Cancer Inst; 1987 Apr; 78(4):667-73. PubMed ID: 2435943
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of a human liposarcoma cell line (HTLS) from the retroperitoneal liposarcoma.
Kiguchi K; Ishiwata I; Ishiwata E; Koshitaka Y; Ohara T; Okudai Y; Sato S; Kobayashi Y; Ishizuka B; Ishikawa H
Hum Cell; 2005 Mar; 18(1):45-52. PubMed ID: 16130899
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of a human thyroid carcinoma cell line (HOTHC) producing colony stimulating factor.
Ishiwata I; Ono I; Kiguchi K; Ishiwata C; Soma M; Ishikawa H
Hum Cell; 2005 Sep; 18(3):163-9. PubMed ID: 17022149
[TBL] [Abstract][Full Text] [Related]
24. Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor.
Franklin M; Gentles L; Matheson E; Bown N; Cross P; Ralte A; Gilkes-Immeson C; Bradbury A; Zanjirband M; Lunec J; Drew Y; O'Donnell R; Curtin NJ
Cancer Med; 2018 Sep; 7(9):4744-4754. PubMed ID: 30109783
[TBL] [Abstract][Full Text] [Related]
25. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
[TBL] [Abstract][Full Text] [Related]
26. Trisomy of chromosome 10 in two cases of ovarian carcinoma.
Wang J; Mes-Masson AM; Tonin PN; Provencher D; Eydoux P
Cancer Genet Cytogenet; 2000 Apr; 118(1):65-8. PubMed ID: 10731594
[TBL] [Abstract][Full Text] [Related]
27. Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer.
Nakazato T; Kanuma T; Tamura T; Faried LS; Aoki H; Minegishi T
Int J Gynecol Cancer; 2007; 17(2):426-32. PubMed ID: 17309563
[TBL] [Abstract][Full Text] [Related]
28. Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.
Nomura H; Tamada Y; Miyagi T; Suzuki A; Taira M; Suzuki N; Susumu N; Irimura T; Aoki D
Oncol Res; 2006; 16(6):289-97. PubMed ID: 17476974
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a new cell line (TAYA) of clear cell adenocarcinoma of the ovary and its radiosensitivity.
Saga Y; Suzuki M; Machida S; Ohwada M; Sato I
Oncology; 2002; 62(2):180-4. PubMed ID: 11914605
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of a lymphoepithelial-like carcinoma cell line (HUUCLEC) derived from the human uterine cervix.
Kiguchi K; Ishiwata I; Tokieda Y; Iguchi M; Ishiwata C; Iwata M; Ishizuka B; Yoshikawa H; Tachibana T; Hashimoto H; Ishikawa H
Hum Cell; 2002 Jun; 15(2):97-102. PubMed ID: 12227504
[TBL] [Abstract][Full Text] [Related]
31. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of an estrogen-producing human ovarian granulosa tumor cell line.
Ishiwata I; Ishiwata C; Soma M; Kobayashi N; Ishikawa H
J Natl Cancer Inst; 1984 Apr; 72(4):789-800. PubMed ID: 6323807
[TBL] [Abstract][Full Text] [Related]
33. IGFBP-1 is expressed specifically in ovarian clear cell adenocarcinoma.
Sugita S; Morishita Y; Kano J; Furuya S; Shiba-Ishii A; Noguchi M
Histopathology; 2011 Apr; 58(5):729-38. PubMed ID: 21457161
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a human ovarian granulosa tumor cell line (HSOGT).
Kondo H; Kiguchi K; Okamura A; Okuma Y; Iida T; Kobayashi Y; Takagi M; Ishizuka B; Ishiwata I
Hum Cell; 2003 Sep; 16(3):123-9. PubMed ID: 15005243
[TBL] [Abstract][Full Text] [Related]
35. In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM).
Ishiwata I; Ishiwata C; Ishiwata E; Sato Y; Kiguchi K; Tachibana T; Ishikawa H
Hum Cell; 2004 Dec; 17(4):211-7. PubMed ID: 16035506
[TBL] [Abstract][Full Text] [Related]
36. [Early malignant changes in ovarian epithelium--the relationship between histology and molecular biological change].
Ichikawa Y
Hum Cell; 2000 Mar; 13(1):3-6. PubMed ID: 10937341
[No Abstract] [Full Text] [Related]
37. Establishment and characterization of a human ovarian sarcomatoid carcinoma cell line BUPH:OVSC.
Guo HF; Feng J; Liu G; Cui H; Ye X; Yao Y; Fu T
Int J Gynecol Cancer; 2005; 15(5):856-65. PubMed ID: 16174236
[TBL] [Abstract][Full Text] [Related]
38. Mixed angiosarcoma, clear cell adenocarcinoma and mature teratoma elements in an ovarian tumor: a case report and literature review.
Takahashi H; Chaopotong P; Kajita S; Hashimura M; Yamazaki H; Saegusa M
Pathol Int; 2012 Aug; 62(8):538-42. PubMed ID: 22827762
[TBL] [Abstract][Full Text] [Related]
39. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
Ezawa S; Suzuki N; Ohie S; Higashiguchi A; Hosoi F; Kitazato K; Susumu N; Aoki D
Gynecol Oncol; 2008 Mar; 108(3):627-31. PubMed ID: 18048092
[TBL] [Abstract][Full Text] [Related]
40. Annexin IV is differentially expressed in clear cell carcinoma of the ovary.
Miao Y; Cai B; Liu L; Yang Y; Wan X
Int J Gynecol Cancer; 2009 Dec; 19(9):1545-9. PubMed ID: 19955935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
